We are the leading Spanish company marketing R&D products nationally and internationally.

Strategic alliances

Our international prestige has led us to establish strategic alliances with internationally renowned pharmaceutical companies for the marketing of our drugs.

Our priority is to continue establishing collaborations to have innovative drugs that contribute to guaranteeing our international establishment. We also collaborate with small and medium sized companies in the development of some of their drugs to register them for marketing in main markets.

Active ingredient Company Commercialization agreements
AcamprosateLIPHA (Merck KgaA)Spain
AlitretinoineBasilea PharmaceuticalsAustria, Belgium, Czech Rep., Italy, Luxembourg, Mexico, Netherlands, Poland, Portugal, Slovakia and Spain
Amlodipine + AtorvastatinePfizerSpain
AtorvastatinPfizerSpain
AzitromicinePfizerSpain
BalsalazideGlaxo SmithklineGreat Britain
GLYCYXGreat Britain
BazedoxifenePfizerSpain
CandesartanTakedaSpain
CitalopramLundbeckSpain
Diclofenac sodiumSkyePharmaAustralia, EU-27, Malaysia, New Zealand, Singapore, South Africa, South Korea, Switzerland and Thailand
Doxazosin GITSPfizerSpain
EflornithineSkinMedicaAustralia, Canada, EU-27, Hong Kong, Israel, New Zealand, Singapore, South Africa, South Korea, Switzerland, Taiwan and Thailand
EplerenonaPfizerSpain
EscitalopramLundbeckSpain
EtodolacWyethGreat Britain
Fluticasone + SalmeterolGlaxo SmithklineSpain
GlucosamineBioibéricaSpain
Iron Succinyl-protein complexItalfarmacoPortugal
LansoprazolTakedaSpain
LinaclotideIronwoodEU-27
MeptazinolWyethGreat Britain
MethocarbamolWyethGreat Britain
Naproxen sodium saltRecordatiItaly
NimodipineBayer AGSpain
PantoprazolNycomedItaly
RamiprilSanofi AventisSpain
RoflumilastNycomedSpain
SilodosineRecordatiSpain
SitagliptinMerck Sharp & DohmeSpain
Sitagliptin + MetforminMerck Sharp & DohmeSpain
TeophillineRecordatiItaly
THC + CBD (Sativex)GW PharmaceuticalsEurope (apart from Great Britain)
TiclopidineSanofi AventisSpain
TolterodinePfizerSpain
VenlafaxineWyethSpain
Active ingredient Company Commercialization agreements
AceclofenacAbiogenItaly
Angelini FarmacéuticaSpain
Cooper MarocMorocco
CrinosItaly
DaewoongSouth Korea
Distribuidores diversosAfrica, Central America, Latin America and Middle East
Droguerie PhenicieLebanon
EurofarmaBrazil
GalenicaGreece
Gedeon RichterBulgaria, CIS, Czech Rep., Estonia, Hungary, Latvia, Lithuania, Poland, Romania and Slovakia
Glaxo SmithklineEgypt
Highnoon Labs.Pakistán
NovisGreece
NycomedTurkey and Venezuela
Aclidinium bromideForestUnited States
KyorinJapan
AlmagateJE-ILSouth Korea
YuhanSouth Korea
AlmotriptanJanssen-OrthoCanada and United States
MedaDenmark, Finland, Iceland, Norway and Sweden
PharmachemieNetherlands
YuhanSouth Korea
CinitaprideEisaiChina
LácerSpain
RecordatiSpain
CleboprideBoryungSouth Korea
Orfi Farma (Wyeth)Spain
Diclofenac sodiumCSLAustralia
EbastineAspen PharmacareSouth Africa
BMSEgypt
BoryungSouth Korea
ChiesiItaly
DainipponJapan
Distribuidores diversosAfrica, Latin America and Middle East
EczacibasiTurkey
EisaiChina
EurofarmaBrazil
GrünenthalEquador
Highnoon Labs.Pakistán
NovisGreece
NycomedCIS, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, Russia, Sweden and Venezuela
Orient EuropharmaTaiwan
RanbaxySingapore and Vietnam
EflornithineCSLAustralia
MedisonIsrael
TritonCanada
Miscellaneous Derma ProductsDong-ASouth Korea
GalenaHungary
InovaHong Kong, Malaysia and Singapore
NeopharmIsrael
OlvosGreece
PiketoprofenGrünenthalPortugal
ItalfarmacoPortugal

Contact us

Would you like further information?

All fields are compulsory